Screener
Regenxbio RGNX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Regenxbio’s reported figures.
Based on trailing twelve months.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
FAQ
- What is Regenxbio's EBITDA margin?
- Regenxbio (RGNX) reported EBITDA margin of -85.3% in Q2 2026.
- How has Regenxbio's EBITDA margin changed year-over-year?
- Regenxbio's EBITDA margin increased by 10.7% year-over-year, from -95.5% to -85.3%.
- What is the long-term trend for Regenxbio's EBITDA margin?
- Over 5 years (2020 to 2025), Regenxbio's EBITDA margin has grown at a 3.6% compound annual growth rate (CAGR), from -71.7% to -85.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Regenxbio's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude